摘要
A series of novel l-lysine derivatives were designed, synthesized, and assayed for their inhibitory activities on amino-peptidase N (APN)/CD13 and matrix metalloproteinase-2 (MMP-2). The preliminary biological test showed that most of the compounds displayed a high inhibitory activity against MMP-2 and a low activity against APN except compound B6 which exhibited good potency (IC50 = 13.2 μM) similar with APN inhibitor Bestatin (IC50=15.5 μM), and could be used as lead compound in the future.
| 源语言 | 英语 |
|---|---|
| 页(从-至) | 5473-5481 |
| 页数 | 9 |
| 期刊 | Bioorganic and Medicinal Chemistry |
| 卷 | 16 |
| 期 | 10 |
| DOI | |
| 出版状态 | 已出版 - 15 5月 2008 |
| 已对外发布 | 是 |
学术指纹
探究 'Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors' 的科研主题。它们共同构成独一无二的学术指纹。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver